STOCKHOLM, April 16, 2019 /PRNewswire/ -- Moberg Pharma´s Annual Report for 2018 has been published and is available on www.mobergpharma.com
About this information
This is information that Moberg Pharma AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation (MAR). The information was submitted for publication, through the contact persons set out below at 08.30 CET on April 16, 2019.
For additional information, please contact:
Peter Wolpert, CEO, phone: +46-707-35-7135, e-mail: peter.wolpert@mobergpharma.se
Anna Ljung, CFO, phone: +46-707-66-6030, e-mail: anna.ljung@mobergpharma.se
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/moberg-pharma/r/moberg-pharma-annual-report-2018,c2789532
The following files are available for download:
Moberg Pharma Annual Report 2018 |
SOURCE Moberg Pharma
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.